Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation-Reference-Cited by-同舟云学术

Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation

Published:2012-04 Issue:3 Volume:24 Page:162-168
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Vianello F.,Mazzarotto R.,Mian C.,Lora O.,Saladini G.,Servodio O.,Basso M.,Pennelli G.,Pelizzo M.R.,Sotti G.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference32 articles.

1. Editorial: a randomized trial of remnant ablation in search of an impossible dream?;Mazzaferri;J Clin Endocrinol Metab,2004

2. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice;Schlumberger;Eur J Endocrinol,2004

3. The American thyroid association guidelines taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer;Cooper;Thyroid,2006

4. European thyroid cancer taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium;Pacini;Eur J Endocrinol,2006

5. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American association of clinical endocrinologists;Thyroid Carcinoma Task Force;Endocr Pract,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Optimal Activity of Radioactive Iodine for Remnant Ablation in Low/Intermediate Risk Differentiated Thyroid Carcinoma: A Continuous Controversy and Meta-Analysis;Cureus;2021-01-27

2. Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low–intermediate risk differentiated thyroid cancer;Clinical and Translational Imaging;2018-08-28

3. BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience;Clinical Chemistry and Laboratory Medicine (CCLM);2016-09-01

4. The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer;Scientific Reports;2016-06

5. Is There Any True Association Between BRAF V600E Mutation and Recurrence, Particularly in Low-Risk, Papillary Thyroid Cancer?;Journal of Clinical Oncology;2015-08-01